US6214331B1
(en)
*
|
1995-06-06 |
2001-04-10 |
C. R. Bard, Inc. |
Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
|
AR018321A1
(es)
*
|
1998-03-26 |
2001-11-14 |
Alza Corp |
Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
|
US6419935B1
(en)
*
|
1998-07-30 |
2002-07-16 |
L'oreal S.A. |
Cosmetic skin treatment method and cleansing treatment patch
|
US6293923B1
(en)
|
1999-03-15 |
2001-09-25 |
Innoventions, Inc. |
Intravesicular balloon
|
US6383471B1
(en)
*
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
EP1949890A3
(en)
*
|
1999-06-04 |
2011-05-18 |
ALZA Corporation |
Implantable gel compositions and method of manufacture
|
CA2372994C
(en)
*
|
1999-06-04 |
2010-03-23 |
Alza Corporation |
Implantable gel compositions and method of manufacture
|
US6740039B1
(en)
|
1999-08-20 |
2004-05-25 |
Koninklijke Philips Electronics N.V. |
Methods and apparatus for displaying information relating to delivery and activation of a therapeutic agent using ultrasound energy
|
US6527718B1
(en)
|
1999-08-20 |
2003-03-04 |
Brian G Connor |
Ultrasound system for continuous imaging and delivery of an encapsulated agent
|
CN101305994A
(zh)
*
|
2000-04-26 |
2008-11-19 |
沃特森药物公司 |
最小化与奥昔布宁疗法有关的副作用
|
US7029694B2
(en)
*
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US6398718B1
(en)
|
2000-06-15 |
2002-06-04 |
Innoventions, Inc. |
Intravesicular device
|
US6545046B2
(en)
|
2000-08-30 |
2003-04-08 |
Theramax Inc. |
Method for enhanced delivery of oxybutynin and compositions thereof
|
US6699665B1
(en)
*
|
2000-11-08 |
2004-03-02 |
Surface Logix, Inc. |
Multiple array system for integrating bioarrays
|
US6558312B2
(en)
|
2001-03-13 |
2003-05-06 |
Clemson University |
Intraurethral device for incontinence
|
US6899703B2
(en)
*
|
2001-03-13 |
2005-05-31 |
Clemson University |
Intraurethral device for treating or detecting various diseases or infections of the urinary system
|
KR100426636B1
(ko)
*
|
2001-05-18 |
2004-04-08 |
한국과학기술연구원 |
주사 가능한 젤 상의 조성물 및 그의 제조방법
|
US6702744B2
(en)
*
|
2001-06-20 |
2004-03-09 |
Advanced Cardiovascular Systems, Inc. |
Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
|
US7063860B2
(en)
*
|
2001-08-13 |
2006-06-20 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
US8110217B2
(en)
*
|
2001-08-13 |
2012-02-07 |
University Of Pittsburgh |
Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
|
US6878693B2
(en)
|
2001-09-28 |
2005-04-12 |
Solubest Ltd. |
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
US6893431B2
(en)
|
2001-10-15 |
2005-05-17 |
Scimed Life Systems, Inc. |
Medical device for delivering patches
|
US8563592B2
(en)
|
2001-11-01 |
2013-10-22 |
Spectrum Pharmaceuticals, Inc. |
Bladder cancer treatment and methods
|
CA2466148C
(en)
*
|
2001-11-01 |
2013-01-08 |
Spectrum Pharmaceuticals, Inc. |
Medical compositions for intravesical treatment of bladder cancer
|
US7700851B2
(en)
*
|
2001-11-13 |
2010-04-20 |
U.S. Smokeless Tobacco Company |
Tobacco nicotine demethylase genomic clone and uses thereof
|
US8608661B1
(en)
|
2001-11-30 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Method for intravascular delivery of a treatment agent beyond a blood vessel wall
|
US8685427B2
(en)
|
2002-07-31 |
2014-04-01 |
Boston Scientific Scimed, Inc. |
Controlled drug delivery
|
US8133501B2
(en)
|
2002-02-08 |
2012-03-13 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices for controlled drug delivery
|
US7361368B2
(en)
|
2002-06-28 |
2008-04-22 |
Advanced Cardiovascular Systems, Inc. |
Device and method for combining a treatment agent and a gel
|
US8920826B2
(en)
*
|
2002-07-31 |
2014-12-30 |
Boston Scientific Scimed, Inc. |
Medical imaging reference devices
|
US7149874B2
(en)
*
|
2002-08-16 |
2006-12-12 |
Micron Technology, Inc. |
Memory hub bypass circuit and method
|
JP2006506385A
(ja)
*
|
2002-10-22 |
2006-02-23 |
ザ バイオメリックス コーポレーション |
治療剤を小嚢内デリバリーするための方法およびシステム
|
US7597903B2
(en)
*
|
2002-12-02 |
2009-10-06 |
Shenkar College Of Engineering And Design |
Method and composition for producing catheters with antibacterial property
|
WO2004052440A1
(en)
*
|
2002-12-11 |
2004-06-24 |
Coloplast A/S |
A urinary catheter device with a pharmaceutically active composition
|
JP2004246317A
(ja)
*
|
2002-12-20 |
2004-09-02 |
Hitachi Ltd |
冷陰極型フラットパネルディスプレイ
|
US7544192B2
(en)
|
2003-03-14 |
2009-06-09 |
Sinexus, Inc. |
Sinus delivery of sustained release therapeutics
|
US8821473B2
(en)
|
2003-04-15 |
2014-09-02 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
US8038991B1
(en)
|
2003-04-15 |
2011-10-18 |
Abbott Cardiovascular Systems Inc. |
High-viscosity hyaluronic acid compositions to treat myocardial conditions
|
US7641643B2
(en)
|
2003-04-15 |
2010-01-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
AU2004241111B2
(en)
|
2003-05-15 |
2010-05-27 |
Dsm Ip Assets B.V |
Manufacture and use of implantable reticulated elastomeric matrices
|
US20040249364A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Ilya Kaploun |
Device and method for dispensing medication to tissue lining a body cavity
|
EP1646367A4
(en)
*
|
2003-07-21 |
2011-06-15 |
Nesher Solutions Ltd |
ORAL DOSAGE FORMS WITH CONTROLLED RELEASE ON GELLAN RUBBER BASE A NEW PLATFORM TECHNOLOGY FOR MAGNETIC RETENTION
|
NZ528648A
(en)
|
2003-10-02 |
2005-08-26 |
Agres Ltd |
Altering animal waste composition
|
US20050175709A1
(en)
|
2003-12-11 |
2005-08-11 |
Baty Ace M.Iii |
Therapeutic microparticles
|
US7763077B2
(en)
|
2003-12-24 |
2010-07-27 |
Biomerix Corporation |
Repair of spinal annular defects and annulo-nucleoplasty regeneration
|
WO2006013851A1
(ja)
*
|
2004-08-03 |
2006-02-09 |
Nippon Shinyaku Co., Ltd. |
体孔内用デバイス及び持続性製剤
|
US8361490B2
(en)
|
2004-09-16 |
2013-01-29 |
Theracoat Ltd. |
Biocompatible drug delivery apparatus and methods
|
US7854944B2
(en)
|
2004-12-17 |
2010-12-21 |
Advanced Cardiovascular Systems, Inc. |
Tissue regeneration
|
CN101189016B
(zh)
|
2005-04-04 |
2013-03-27 |
因特尔赛克特耳鼻喉公司 |
治疗鼻窦病症的装置
|
US8828433B2
(en)
|
2005-04-19 |
2014-09-09 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
US8303972B2
(en)
*
|
2005-04-19 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
US8187621B2
(en)
*
|
2005-04-19 |
2012-05-29 |
Advanced Cardiovascular Systems, Inc. |
Methods and compositions for treating post-myocardial infarction damage
|
US20080125745A1
(en)
*
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
CA2653541C
(en)
|
2005-06-06 |
2014-12-23 |
The University Of British Columbia |
Polymer-based serum albumin substitute
|
DK1933810T3
(da)
|
2005-08-11 |
2013-01-28 |
Childrens Medical Center |
Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
|
US7732190B2
(en)
*
|
2006-07-31 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
US9242005B1
(en)
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
WO2008035172A2
(en)
*
|
2006-09-18 |
2008-03-27 |
Glenmark Pharmaceuticals Limited |
Pharmaceutical compositions containing desmopressin
|
US8741326B2
(en)
*
|
2006-11-17 |
2014-06-03 |
Abbott Cardiovascular Systems Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
US9005672B2
(en)
*
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
US8192760B2
(en)
|
2006-12-04 |
2012-06-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating tissue using silk proteins
|
US20080161639A1
(en)
*
|
2006-12-28 |
2008-07-03 |
Olympus Medical Systems Corporation |
Capsule medical apparatus and body-cavity observation method
|
US8702591B2
(en)
*
|
2007-01-12 |
2014-04-22 |
Olympus Medical Systems Corp. |
Capsule medical apparatus
|
DE102007003765A1
(de)
*
|
2007-01-19 |
2008-07-24 |
Farco-Pharma Gmbh |
Pharmazeutische Zusammensetzung zur Behandlung von Inkontinenz
|
DK2231254T3
(da)
|
2007-12-11 |
2014-07-21 |
Massachusetts Inst Technology |
Implanterbar lægemiddelafgivelsesindretning
|
AU2008338586B2
(en)
|
2007-12-18 |
2015-01-29 |
Intersect Ent, Inc. |
Self-expanding devices and methods therefor
|
US8763222B2
(en)
|
2008-08-01 |
2014-07-01 |
Intersect Ent, Inc. |
Methods and devices for crimping self-expanding devices
|
EA201170297A1
(ru)
*
|
2008-08-09 |
2011-08-30 |
Массачусетс Инститьют Оф Текнолоджи |
Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
|
US20100291182A1
(en)
*
|
2009-01-21 |
2010-11-18 |
Arsenal Medical, Inc. |
Drug-Loaded Fibers
|
EP2424582B1
(en)
|
2009-04-28 |
2014-10-08 |
AMS Research Corporation |
Biologic treatment system and method
|
US9744142B2
(en)
|
2009-05-05 |
2017-08-29 |
Board Of Regents, The University Of Texas Systems |
Formulations of volatile anesthetics and methods of use for reducing inflammation
|
CA3001814C
(en)
|
2009-05-15 |
2020-12-22 |
Intersect Ent, Inc. |
Expandable devices and methods therefor
|
CN101724163B
(zh)
*
|
2009-06-23 |
2011-09-07 |
河南科技大学 |
一种壳聚糖衍生物复合微球及其制备方法和应用
|
MX2011013539A
(es)
*
|
2009-06-26 |
2012-02-28 |
Taris Biomedical Inc |
Tabletas de farmaco solidas para dispositivos implantables para administrar farmacos.
|
DE102009035586A1
(de)
|
2009-07-31 |
2011-02-03 |
Fresenius Kabi Deutschland Gmbh |
Intravesikale Instillationslösungen zur Behandlung von Blasenkrebs
|
US9044580B2
(en)
|
2009-08-24 |
2015-06-02 |
Arsenal Medical, Inc. |
In-situ forming foams with outer layer
|
US9173817B2
(en)
|
2009-08-24 |
2015-11-03 |
Arsenal Medical, Inc. |
In situ forming hemostatic foam implants
|
US10420862B2
(en)
|
2009-08-24 |
2019-09-24 |
Aresenal AAA, LLC. |
In-situ forming foams for treatment of aneurysms
|
US20110202016A1
(en)
*
|
2009-08-24 |
2011-08-18 |
Arsenal Medical, Inc. |
Systems and methods relating to polymer foams
|
US9017312B2
(en)
|
2009-09-10 |
2015-04-28 |
Taris Biomedical Llc |
Implantable device for controlled drug delivery
|
LT2512581T
(lt)
|
2009-12-17 |
2021-03-25 |
Taris Biomedical Llc |
Intravezikalinio suderinamumo implantuojamas medicininis įtaisas
|
AU2015201123B2
(en)
*
|
2009-12-17 |
2016-04-21 |
Taris Biomedical Llc |
Implantable device with intravesical tolerability and methods of treatment
|
DE212011100034U1
(de)
|
2010-01-20 |
2012-07-04 |
Theracoat Ltd. |
Material zur Behandlung von inneren Hohlräumen
|
US9186410B2
(en)
|
2010-03-01 |
2015-11-17 |
The University Of British Columbia |
Derivatized hyperbranched polyglycerols
|
EP4241764A3
(en)
|
2010-08-05 |
2023-12-20 |
TARIS Biomedical LLC |
Implantable drug delivery devices for genitourinary sites
|
WO2012048114A1
(en)
*
|
2010-10-06 |
2012-04-12 |
Taris Biomedical, Inc. |
Time-selective bioresorbable or collapsible drug delivery systems and methods
|
ES2943334T3
(es)
|
2011-01-10 |
2023-06-12 |
Taris Biomedical Llc |
Régimen de lidocaína para el uso de tratamiento sostenido del dolor de vejiga y micción irritativa
|
US9194058B2
(en)
|
2011-01-31 |
2015-11-24 |
Arsenal Medical, Inc. |
Electrospinning process for manufacture of multi-layered structures
|
US8968626B2
(en)
|
2011-01-31 |
2015-03-03 |
Arsenal Medical, Inc. |
Electrospinning process for manufacture of multi-layered structures
|
US9034240B2
(en)
|
2011-01-31 |
2015-05-19 |
Arsenal Medical, Inc. |
Electrospinning process for fiber manufacture
|
EP2670398B1
(en)
|
2011-02-04 |
2017-06-07 |
TARIS Biomedical LLC |
Implantable device for controlled release of low solubility drug
|
US8476221B2
(en)
|
2011-03-18 |
2013-07-02 |
Halimed Pharmaceuticals, Inc. |
Methods and compositions for the treatment of metabolic disorders
|
EP2734187B1
(en)
|
2011-07-20 |
2018-09-05 |
UroGen Pharma Ltd. |
Materials and method for treating internal body cavities
|
WO2013063127A1
(en)
|
2011-10-24 |
2013-05-02 |
Endo Pharmaceuticals Inc. |
Cyclohexylamines
|
US8993831B2
(en)
|
2011-11-01 |
2015-03-31 |
Arsenal Medical, Inc. |
Foam and delivery system for treatment of postpartum hemorrhage
|
BR112014028916B1
(pt)
|
2012-05-19 |
2022-01-11 |
Taris Biomedical Llc |
Dispositivo médico
|
CN105188831B
(zh)
|
2013-03-14 |
2021-01-01 |
因特尔赛克特耳鼻喉公司 |
用于治疗鼻窦病状的***、装置以及方法
|
MX2015012367A
(es)
|
2013-03-15 |
2016-05-31 |
Taris Biomedical Llc |
Dispositivos de suministro de farmacos con un componente permeable al farmaco y metodos.
|
KR102488491B1
(ko)
|
2013-08-19 |
2023-01-12 |
타리스 바이오메디컬 엘엘씨 |
다중 유닛 약물 전달 장치 및 방법
|
WO2015095128A1
(en)
|
2013-12-16 |
2015-06-25 |
Asana Biosciences, Llc |
P2x3 and/or p2x2/3 compounds and methods
|
CN103861091B
(zh)
*
|
2014-03-20 |
2016-04-27 |
辽宁亿灵科创生物医药科技有限公司 |
治疗膀胱炎的药物组合物
|
KR20230142816A
(ko)
|
2014-06-26 |
2023-10-11 |
타리스 바이오메디컬 엘엘씨 |
탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
|
CZ308594B6
(cs)
*
|
2014-09-29 |
2020-12-23 |
VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. |
Mukoadhezivní nosiče částic, způsob přípravy a použití
|
US10894150B2
(en)
|
2015-04-23 |
2021-01-19 |
Taris Biomedical Llc |
Drug delivery devices with drug-permeable component and methods
|
WO2018064135A1
(en)
|
2016-09-30 |
2018-04-05 |
Asana Biosciences, Llc |
P2x3 and/or p2x2/3 compounds and methods
|
IT201700104446A1
(it)
|
2017-09-19 |
2019-03-19 |
Lo Li Pharma Srl |
Compositions, uses and methods for treatment of infertility and subfertility
|
MX2020006451A
(es)
|
2017-12-22 |
2020-11-06 |
Lo Li Pharma Srl |
Tratamiento de la fibrosis con inositol.
|
EP3856143A4
(en)
*
|
2018-09-27 |
2022-07-06 |
Watershed Medical, Inc. |
DEVICE AND METHOD FOR TREATING INFECTIONS
|
EP3924521A4
(en)
|
2019-02-15 |
2023-03-29 |
IncellDx, Inc. |
BLADDER-ASSOCIATED SPECIMEN ASSAY, IDENTIFICATION AND TREATMENT OF BLADDER-ASSOCIATED NEOPLASIA, AND KITS FOR USE THEREOF
|
IT201900003843A1
(it)
|
2019-03-15 |
2020-09-15 |
Lo Li Pharma Srl |
Trattamento di fibromi con vitamina D e un agente come l'epigallocatechina gallato (EGCG)
|
WO2020222139A1
(en)
*
|
2019-04-30 |
2020-11-05 |
Trigone Pharma Ltd. |
Formulations and methods for drug instillation into the bladder and treatment of bladder ailments
|
WO2021067857A1
(en)
*
|
2019-10-02 |
2021-04-08 |
Watershed Medical, Inc. |
Device and method for improving retention of a therapy in the bladder
|
WO2023205703A2
(en)
*
|
2022-04-19 |
2023-10-26 |
Watershed Medical, Inc. |
Formulation for treating urinary system disorders
|
WO2024003061A1
(en)
|
2022-06-30 |
2024-01-04 |
Lo.Li. Pharma S.R.L. |
Composition for the treatment of the human papillomavirus infection (hpv)
|